AU5553294A - Novel substance dolastatin c and pharmaceutical use thereof - Google Patents

Novel substance dolastatin c and pharmaceutical use thereof

Info

Publication number
AU5553294A
AU5553294A AU55532/94A AU5553294A AU5553294A AU 5553294 A AU5553294 A AU 5553294A AU 55532/94 A AU55532/94 A AU 55532/94A AU 5553294 A AU5553294 A AU 5553294A AU 5553294 A AU5553294 A AU 5553294A
Authority
AU
Australia
Prior art keywords
dolastatin
pharmaceutical use
novel substance
substance
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55532/94A
Inventor
Hisao Ekimoto
Tetsushi Saino
Rie Tanaka
Kiyoyuki Yamada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Kayaku Co Ltd
Original Assignee
Nippon Kayaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Kayaku Co Ltd filed Critical Nippon Kayaku Co Ltd
Publication of AU5553294A publication Critical patent/AU5553294A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G99/00—Subject matter not provided for in other groups of this subclass

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU55532/94A 1992-12-11 1993-12-07 Novel substance dolastatin c and pharmaceutical use thereof Abandoned AU5553294A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP4352439A JPH06172397A (en) 1992-12-11 1992-12-11 New substance dolastain c and its use
JP4-352439 1992-12-11
PCT/JP1993/001774 WO1994013684A1 (en) 1992-12-11 1993-12-07 Novel substance dolastatin c and pharmaceutical use thereof

Publications (1)

Publication Number Publication Date
AU5553294A true AU5553294A (en) 1994-07-04

Family

ID=18424087

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55532/94A Abandoned AU5553294A (en) 1992-12-11 1993-12-07 Novel substance dolastatin c and pharmaceutical use thereof

Country Status (4)

Country Link
JP (1) JPH06172397A (en)
CN (1) CN1098105A (en)
AU (1) AU5553294A (en)
WO (1) WO1994013684A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023033129A1 (en) 2021-09-03 2023-03-09 東レ株式会社 Pharmaceutical composition for treating and/or preventing cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4414205A (en) * 1981-08-28 1983-11-08 University Patents, Inc. Cell growth inhibitory substances
US4486414A (en) * 1983-03-21 1984-12-04 Arizona Board Of Reagents Dolastatins A and B cell growth inhibitory substances

Also Published As

Publication number Publication date
CN1098105A (en) 1995-02-01
WO1994013684A1 (en) 1994-06-23
JPH06172397A (en) 1994-06-21

Similar Documents

Publication Publication Date Title
AU2505795A (en) 1-arylpyrimidine derivatives and pharmaceutical use thereof
AU1618697A (en) Novel compounds and pharmaceutical use thereof
AU5681294A (en) Tastemasked pharmaceutical materials
AU1590995A (en) Novel carbamate derivative and medicinal composition containing the same
AU7545894A (en) Carbamate derivative and medicine containing the same
KR950703566A (en) Thienodiazepine compound and its pharmaceutical use [THIENODIAZEPINE COMPOUND AND MEDICINAL USE THEREOF]
AU2157192A (en) 4-aminoquinolines and pharmaceutical compositions thereof
AU7237394A (en) Morphinan derivative and medicinal use
HU9303282D0 (en) Pharmaceutical preparations containing hialuronic acid and/or derivatives and/or fragments
HUP0000474A3 (en) Arylethenesulfonamide derivatives and drug composition containing the same
HU9602104D0 (en) Novel medicines and their use
AU3171997A (en) Cosmetic and/or pharmaceutical preparations
HU9303283D0 (en) Pharmaceutical preparations containing hialuronic acid and/or derivatives and/or fragments
AU3720193A (en) Hydroisoindolines and hydroisoquinolines as psychotropic drugs
AU5067193A (en) Pyranoquinolines and their use as pharmaceuticals
GB9504040D0 (en) Arylsulfonamide derivative and pharmaceutical composition containing the same
AU7275894A (en) Imidazolylalkylamine derivative and pharmaceutical composition thereof
AU4100593A (en) Iminoalcohol-oxazolidine mixtures and their use
AU7000896A (en) Novel peptide compounds and medicinal compositions thereof
AU4123396A (en) Cephem compounds and pharmaceutical use thereof
GB9501286D0 (en) Pharmaceutical compositions and preparations thereof
AU6318896A (en) Benzamidoxime derivatives and medicinal use thereof
AU6690394A (en) Imidazolylquinoxalinedione derivative and pharmaceutical composition thereof
AU7352396A (en) Use of protein S-100b in medicines and medicines containing the protein S-100-b
HUP9602220A3 (en) Substituted 4h-piranes and pharmaceutical preparations containing them